Philadelphia, PA | July 2021 – RatnerPrestia’s James Matthew Gould will be presenting an interactive case study in the pharmaceutical patent litigation space on July 22, 2021, at the American Conference Institute‘s upcoming 19th Advanced Summit on Life Sciences Patents. His topic will focus on allegations of patent infringement when generic companies carve out patented indications […]
Read more
by Christopher H. Blaszkowski & Shayne D. Rasay In United States v. Arthrex, Inc., 594 U.S. ___ (2021), the Supreme Court determined that the authority exercised by Administrative Patent Judges (APJs) in rendering inter partes review (IPR) decisions as members of the Patent Trial and Appeal Board (PTAB) violates the Appointments Clause of the Constitution. […]
Read more
By Jonathan H. Spadt & Andrew J. Koopman This month, the Biden administration announced its support for a waiver of intellectual property (IP) protections relating to the production of COVID-19 vaccines. Few would take issue with the purported goal of such a waiver—speeding access to these life-saving vaccines in nations still deep in the throes […]
Read more
by Jonathan H. Spadt & Christopher H. Blaszkowski On April 9, 2021, Senator Thom Tillis (R-NC), the Honorable Paul Michel, and the Honorable Andrei Iancu submitted a joint amicus brief in Samsung’s appeal of Judge Gilstrap’s anti-interference injunction. Without taking a position on the exact nature of the injunction required, the brief argued in favor […]
Read more
by Glenn E.J. Murphy Both Forbes and the New York Times report that about twenty percent of new businesses formed in 2021 will fail within their first year of existence, about thirty percent within two years, about fifty percent within five years, and about seventy percent will fail by their tenth year. But even those […]
Read more
Washington, D.C. | April 2021 – RP CEO Jonathan H. Spadt, will be moderating a set of important and timely exchanges on April 29 as a part of the on-going Global Series meetings of the Federal Circuit Bar Association. The virtual meeting, scheduled for 11:00 a.m. EDT – 12:30 p.m. EDT, will open with a […]
Read more
Washington, D.C. | March 2021 – RatnerPrestia is honored to have been selected as a Member Company of the Board of Directors of the German American Business Council (GABC). RP has been represented by its CEO, Jonathan H. Spadt, as a Leadership Member of the GABC since 2010. Founded as an initiative of the Embassy […]
Read more
Washington, D.C. | March 2021 – RatnerPrestia is pleased to welcome Ben Xiaobin You to the firm in the District of Columbia Office. As an IP attorney, Ben will focus on electrical and mechanical technologies as it relates to the building, maintaining and enforcing patents for inventions. As a patent prosecutor before the United States […]
Read more
by Jonathan H. Spadt & Christopher H. Blaszkowski Not long ago, legal work on standard essential patents (“SEPs”) was largely limited to the telecommunications industry. With the expansion of communication software and protocols into nearly every industry today, however, having knowledge of the issues relevant to SEPs and the associated obligations of SEP holders to […]
Read more
Philadelphia, PA | January 2021 – RatnerPrestia litigators Christopher Blaszkowski and Andrew Koopman recently prevailed in an inter partes review proceeding in which they represented Petitioner Remediation Products, Inc. The final written decision, which issued on January 15, cancelled every claim of U.S. Patent No. 7,531,709 (“the ‘709 Patent”). The ‘709 Patent “relates to an […]
Read more
Previous Entries Next Entries
